There are 398 resources available
243P - The landscape of RUNX1 mutations in breast cancer and its therapeutic potential
Presenter: Nur Syamimi Ariffin
Session: Poster Display session
244P - The incidence of infusion related reactions with trastuzumab-emtansine
Presenter: Parvin Begum
Session: Poster Display session
245P - A multidisciplinary virtual intervention to addresses information needs of Mexican patients with breast cancer
Presenter: Rosa Lidia Bejarano
Session: Poster Display session
246P - DNA repair protein RAD51 homolog 1 (RAD51), a potential prognostic biomarker and target for breast cancer
Presenter: Yin-Quan Tang
Session: Poster Display session
247P - Usage and side effects of each common Aromatase Inhibitor in 5 large European countries: real world data analysis
Presenter: Paris Kosmidis
Session: Poster Display session
248P - Axillary nodal involvement (ANI) predictive model by primary histopathological features in invasive breast cancer (IBC): a real-world analysis of 1,400 cases
Presenter: Bruno Cutuli
Session: Poster Display session
249P - Significance of intraoperative frozen assessment of cavity shave margins in patients undergoing breast conservation surgery: a tertiary care centre experience
Presenter: Priyansh Jain
Session: Poster Display session
Welcome and introductions
Presenter: Michael Lux
Session: Pfizer Oncology - Broadening horizons in HER2- advanced breast cancer
Resources:
Webcast
Introduction
Presenter: Volkmar Müller
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast
Patient case study: how does treatment sequencing vary in local clinical practice across Europe for HER2-positive MBC?
Presenter: Volkmar Müller
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast